H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease

Abstract Amyloid‐β (Aβ) and Tau proteins are the main components of Aβ plaques and neurofibrillary tangles in Alzheimer's disease (AD), and their abnormal aggregation is closely related to the pathogenesis of AD. The production of reactive oxygen species (ROS) and the aggregation of Aβ and Tau...

Full description

Bibliographic Details
Main Authors: Luying Qiao, Yang Shen, Shiyu Zhang, Man Wang, Guanglei Lv, Qingqing Dou, Chunxia Li
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:BMEMat
Subjects:
Online Access:https://doi.org/10.1002/bmm2.12011
_version_ 1827904859529019392
author Luying Qiao
Yang Shen
Shiyu Zhang
Man Wang
Guanglei Lv
Qingqing Dou
Chunxia Li
author_facet Luying Qiao
Yang Shen
Shiyu Zhang
Man Wang
Guanglei Lv
Qingqing Dou
Chunxia Li
author_sort Luying Qiao
collection DOAJ
description Abstract Amyloid‐β (Aβ) and Tau proteins are the main components of Aβ plaques and neurofibrillary tangles in Alzheimer's disease (AD), and their abnormal aggregation is closely related to the pathogenesis of AD. The production of reactive oxygen species (ROS) and the aggregation of Aβ and Tau form a vicious circle, which leads to the aggravation of AD. However, inhibiting the aggregation of Aβ and Tau or scavenging ROS is not able to effectively reverse the progression of AD. Herein, we prepared a H2O2 responsive multifunctional nanocomposite UCNPs@mSiO2‐MB@AuNPs (abbreviated as USMA) to inhibit the aggregation of Aβ and Tau. In this system, USMA could respond to H2O2 to detach gold nanoparticles (AuNPs) and lead to the release of methylene blue (MB) from mesoporous silica (mSiO2), where AuNPs and MB can inhibit Aβ and Tau aggregation, respectively. Furthermore, USMA could consume H2O2 by reacting with them. Meanwhile, upconversion luminescence of UCNPs can be used to track USMA and monitor MB release, which could provide information on the content of MB in the lesion area. Importantly, the USMA can effectively reduce the cytotoxicity induced by Aβ and Tau aggregation. This work opens up a possibility to improve therapeutic efficacy for the treatment of AD.
first_indexed 2024-03-13T00:33:21Z
format Article
id doaj.art-d64f774bbca24343ace70dac2bfe419d
institution Directory Open Access Journal
issn 2751-7446
language English
last_indexed 2024-03-13T00:33:21Z
publishDate 2023-03-01
publisher Wiley
record_format Article
series BMEMat
spelling doaj.art-d64f774bbca24343ace70dac2bfe419d2023-07-10T09:35:31ZengWileyBMEMat2751-74462023-03-0111n/an/a10.1002/bmm2.12011H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's diseaseLuying Qiao0Yang Shen1Shiyu Zhang2Man Wang3Guanglei Lv4Qingqing Dou5Chunxia Li6Institute of Molecular Sciences and Engineering Institute of Frontier and Interdisciplinarity Science Shandong University Qingdao ChinaInstitute of Molecular Sciences and Engineering Institute of Frontier and Interdisciplinarity Science Shandong University Qingdao ChinaSchool of Environmental Science and Engineering Shandong University Qingdao ChinaInstitute of Molecular Sciences and Engineering Institute of Frontier and Interdisciplinarity Science Shandong University Qingdao ChinaCenter for Biotechnology and Biomedical Engineering Yiwu Research Institute of Fudan University Yiwu ChinaInstitute of Material Research & Engineering Agency for Science, Technology and Research (A*STAR) Singapore SingaporeInstitute of Molecular Sciences and Engineering Institute of Frontier and Interdisciplinarity Science Shandong University Qingdao ChinaAbstract Amyloid‐β (Aβ) and Tau proteins are the main components of Aβ plaques and neurofibrillary tangles in Alzheimer's disease (AD), and their abnormal aggregation is closely related to the pathogenesis of AD. The production of reactive oxygen species (ROS) and the aggregation of Aβ and Tau form a vicious circle, which leads to the aggravation of AD. However, inhibiting the aggregation of Aβ and Tau or scavenging ROS is not able to effectively reverse the progression of AD. Herein, we prepared a H2O2 responsive multifunctional nanocomposite UCNPs@mSiO2‐MB@AuNPs (abbreviated as USMA) to inhibit the aggregation of Aβ and Tau. In this system, USMA could respond to H2O2 to detach gold nanoparticles (AuNPs) and lead to the release of methylene blue (MB) from mesoporous silica (mSiO2), where AuNPs and MB can inhibit Aβ and Tau aggregation, respectively. Furthermore, USMA could consume H2O2 by reacting with them. Meanwhile, upconversion luminescence of UCNPs can be used to track USMA and monitor MB release, which could provide information on the content of MB in the lesion area. Importantly, the USMA can effectively reduce the cytotoxicity induced by Aβ and Tau aggregation. This work opens up a possibility to improve therapeutic efficacy for the treatment of AD.https://doi.org/10.1002/bmm2.12011Alzheimer's diseaseAmyloid‐βTauupconversion nanoparticles
spellingShingle Luying Qiao
Yang Shen
Shiyu Zhang
Man Wang
Guanglei Lv
Qingqing Dou
Chunxia Li
H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
BMEMat
Alzheimer's disease
Amyloid‐β
Tau
upconversion nanoparticles
title H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
title_full H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
title_fullStr H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
title_full_unstemmed H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
title_short H2O2‐responsive multifunctional nanocomposite for the inhibition of amyloid‐β and Tau aggregation in Alzheimer's disease
title_sort h2o2 responsive multifunctional nanocomposite for the inhibition of amyloid β and tau aggregation in alzheimer s disease
topic Alzheimer's disease
Amyloid‐β
Tau
upconversion nanoparticles
url https://doi.org/10.1002/bmm2.12011
work_keys_str_mv AT luyingqiao h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease
AT yangshen h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease
AT shiyuzhang h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease
AT manwang h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease
AT guangleilv h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease
AT qingqingdou h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease
AT chunxiali h2o2responsivemultifunctionalnanocompositefortheinhibitionofamyloidbandtauaggregationinalzheimersdisease